Status:
COMPLETED
Pain Neuroscience Education in Diabetic Neuropathy
Lead Sponsor:
Riphah International University
Conditions:
Pain, Neuropathic
Diabetic Nephropathy
Eligibility:
All Genders
50-70 years
Phase:
NA
Brief Summary
To determine the effects of Pain Neuroscience Education in Diabetic Neuropathy
Detailed Description
Pain neuroscience education (PNE) has shown to have immediate effects on various clinical signs and symptoms associated with central sensitization. Using a model of (innocuous, noxious and allodynia) ...
Eligibility Criteria
Inclusion
- History of diabetic ≥ 5 years
- HbA1C higher and equal to 6.5 %
- Self-completed Leeds Assessment of Neuropathic Symptoms and Signs pain scale (S-LANSS) ≥ 12
- Mini Mental State Examination (MMSE) score ≥ 24
Exclusion
- Known neurological disorder
- Foot ulcers/candidate of amputation
- Hearing impaired
Key Trial Info
Start Date :
August 13 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2021
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT04721847
Start Date
August 13 2020
End Date
August 31 2021
Last Update
September 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Allied Hospital
Faisalabad, Punjab Province, Pakistan, 46000